The pharmaceutical giant Eli Lilly's stock has been riding the skyrocketing demand for its weight loss injection Zepbound and ...

While Novo Nordisk and Pfizer intensify their plays, Lilly’s early lead in GLP-1 treatments has put it in a category all its ...

Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by ...

Eli Lilly, the maker of hugely popular weight loss drugs, has reached $1 trillion in value, becoming the first publicly ...

The pharmaceutical company’s success developing medicines for obesity has swelled its worth to levels associated with tech ...

Eli Lilly has broken free from the Big Pharma pack. Fueled by sky-high expectations for the GLP-1 market, Lilly has achieved ...

Eli Lilly just hit a new kind of orbit. Investors pushed Eli Lilly past the $1 trillion mark on Friday as its shares climbed ...

Eli Lilly has officially entered the elite $1 trillion market-value club, becoming the first pharmaceutical company to reach ...

Eli Lilly has made history by becoming the first healthcare company in the world to reach a staggering $1 trillion market capitalization, a milestone typically reserved for tech giants. This ...

Eli Lilly posts 54% revenue growth, raises guidance, and drives innovation in obesity and diabetes care. Read here for an ...

Eli Lilly’s Zepbound push is getting a “Queer Eye” makeover with the help of fashion expert Tan France, who is joining the ...

Eli Lilly has become the first healthcare company to hit a $1 trillion market value, entering an exclusive club dominated by ...